Artificial intelligence disease detection and care coordination platform Viz.ai launched Thursday an integrated AI-solution to help healthcare organizations streamline pulmonary care.
The newly announced Viz Pulmonary Suite combines acute and chronic pulmonary workflows into a single solution, integrated with electronic health records (EHRs) within the Viz platform. It’s the “first comprehensive” AI-driven solution for such care, the company says.
Viz.ai Chief Medical Officer Tim Showalter, M.D., told Fierce Healthcare the Studio ensures “the right patient gets to the right physician at the right time.”
“There are a few features that the suite includes that provide a lot of assistance for making sure that patients consistently get the right treatment,” Showalter said. “[That] includes chart summarization, through an EHR integration, so that clinicians have the most accurate information available when they see the patient, as well as guideline support for what are the best next steps.”
Viz Pulmonary Suite’s goal is to prevent missed diagnoses and treatment delays for major pulmonary conditions. It aids in the care of major pulmonary conditions, including chronic obstructive pulmonary disease (COPD), lung nodules and pulmonary embolisms.
Showalter said the new tool contains a feature that can “identify pulmonary embolism directly” on scans and identify clots that can be treated. “We've seen already that that has decreased time in the hospital and improved survival rates for patients with pulmonary embolism,” he said.
The combination of Viz’s vast scale and EHR integration makes the platform “unique,” according to Showalter.
“We're able to not only identify patients based on radiology scans, but also provide clinicians the information they need to quickly digest what's actually going on with that patient and take fast action to deliver the right care,” Showalter said.
In late March, the company also rolled out Viz Agent Studio, which it says is the first agentic platform for health systems to build and deploy their own customizable care pathways.
The tool allows healthcare organizations to translate clinical guidelines into workflows, then deploy and scale them "across the enterprise using natural language," executives said.
Since the company’s 2016 launch, its platform has been deployed at 2,000 hospitals across the U.S., a scale that CEO and co-founder Chris Mansi, M.D., told Fierce Healthcare covers “two-thirds” of the country’s population.